2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantamab & Lazertinib as 1L Treatment in Patients With EGFRm Advanced NSCLC"

110 views
June 11, 2024
0 Comments
Login to view comments. Click here to Login
Lung